T&T goes ahead with AstraZeneca vaccine rollout by SHIRLEY BAHADUR Even as the World Health Organisation (WHO) continues to investigate if recent blood clotting incidents in patients from certain countries in the European Union (EU) was a direct cause of the AstraZeneca vaccine, local health officials have assured T&T can go ahead with rolling out this vaccine to its population. Commenting on concerns after few countries in the EU suspended the administration of this particular vaccine, epidemiologist Dr Avery Hinds and Medical Chief of Staff at the Eric Williams Medical Sciences Complex Dr Joanne Paul said there were still strong recommendations from experts relating to the protection that this vaccine can provide.